• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    2/9/23 11:12:44 AM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email
    SC 13G/A 1 tv0568-chemoursco.htm SCHEDULE 13G/A chemoursco

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 8)*

    Name of issuer:  Chemours Co.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  163851108

    Date of Event Which Requires Filing of this Statement: December 30, 2022

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  163851108

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    84,123

    7.  SOLE DISPOSITIVE POWER

    18,196,342

    8.  SHARED DISPOSITIVE POWER

    219,811

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    18,416,153

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    12.20%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Chemours Co.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    1007 Market Street
    Wilmington, DE 19801

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    163851108

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2023

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $CC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Mather Courtney

      4 - Chemours Co (0001627223) (Issuer)

      7/2/25 4:15:42 PM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Satterthwaite Livingston

      4 - Chemours Co (0001627223) (Issuer)

      7/2/25 4:15:34 PM ET
      $CC
      Major Chemicals
      Industrials
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Chemours Company Provides Update on Second Quarter 2025 Outlook

      The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today provided an update on its second quarter 2025 outlook. For the second quarter of 2025, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon™ Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40%

      6/18/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chemours upgraded by Mizuho with a new price target

      Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

      3/27/25 8:05:02 AM ET
      $CC
      Major Chemicals
      Industrials
    • Truist initiated coverage on Chemours with a new price target

      Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

      1/28/25 7:09:50 AM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours upgraded by UBS with a new price target

      UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

      7/9/24 8:13:51 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      6/4/25 8:32:18 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

      4 - Chemours Co (0001627223) (Issuer)

      5/21/25 5:13:57 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chemours Company

      SC 13G/A - Chemours Co (0001627223) (Subject)

      11/12/24 9:55:16 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      2/9/24 8:50:19 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Chemours Company (Amendment)

      SC 13G/A - Chemours Co (0001627223) (Subject)

      1/24/24 9:46:44 AM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Chemours Company

      SCHEDULE 13G - Chemours Co (0001627223) (Subject)

      6/10/25 4:00:13 PM ET
      $CC
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Chemours Company

      SCHEDULE 13G/A - Chemours Co (0001627223) (Subject)

      6/6/25 10:03:48 AM ET
      $CC
      Major Chemicals
      Industrials
    • SEC Form SD filed by Chemours Company

      SD - Chemours Co (0001627223) (Filer)

      5/29/25 4:35:48 PM ET
      $CC
      Major Chemicals
      Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    See more
    • Chemours Appoints Matthew Conti as Chief Human Resources Officer

      Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

      6/12/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

      The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

      6/10/25 6:45:00 AM ET
      $CC
      Major Chemicals
      Industrials
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance

    $CC
    Financials

    Live finance-specific insights

    See more
    • Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo

      4/16/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces First Quarter Dividend

      The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut

      2/14/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials
    • Chemours Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast Conference Call

      The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (

      2/3/25 4:30:00 PM ET
      $CC
      Major Chemicals
      Industrials